Global Active Pharmaceutical Ingredient Market Research Report 2017

医薬品有効成分の世界市場

◆タイトル:Global Active Pharmaceutical Ingredient Market Research Report 2017
◆商品コード:QYR7055235
◆調査・発行会社:QYResearch
◆発行日:2017年5月9日
◆ページ数:123
◆レポート形式:(印刷可能)PDF / 英語
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル
◆産業分野:医療
◆販売価格オプション(消費税別)
Single UserUSD2,900 ⇒換算¥327,700見積依頼/購入/質問フォーム
Enterprise(全社内共有可)USD5,800 ⇒換算¥655,400見積依頼/購入/質問フォーム
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常2日~3日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearchの日本における正規販売代理店です。

【レポートの概要】

当調査レポートでは、世界の医薬品有効成分市場について調査・分析し、医薬品有効成分のグローバル市場概観、医薬品有効成分の種類別市場分析、用途別市場分析、医薬品有効成分の世界市場規模予測、関連企業分析、主要地域別分析(北米/アメリカ市場、欧州市場、中国市場、日本市場、アジア市場など)、関連企業情報、価格情報、販売動向、市場動向、貿易動向、市場環境分析情報などを含め、以下の構成でお届けいたします。

・医薬品有効成分の世界市場概観
・医薬品有効成分の種類別市場規模
・医薬品有効成分の用途別市場規模
・医薬品有効成分の世界市場規模
・医薬品有効成分の世界市場規模予測
・医薬品有効成分の主要地域別市場規模
・医薬品有効成分の北米(アメリカ)市場規模・予測
・医薬品有効成分の欧州市場規模・予測
・医薬品有効成分の中国市場規模・予測
・医薬品有効成分の日本市場規模・予測
・医薬品有効成分のアジア市場規模・予測
・医薬品有効成分の製造メーカー分析
・医薬品有効成分のメーカー別生産量
・医薬品有効成分のメーカー別市場シェア
・医薬品有効成分の価格動向・価格分析
・医薬品有効成分の販売(売上高)動向
・医薬品有効成分の貿易(輸出・輸入)動向
・医薬品有効成分の産業チェーン分析
・医薬品有効成分のマーケティング戦略分析
・医薬品有効成分の販売業者(代理店)リスト
・医薬品有効成分の市場環境分析
...

In this report, the global Active Pharmaceutical Ingredient market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.
Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Active Pharmaceutical Ingredient in these regions, from 2012 to 2022 (forecast), covering
North America
Europe
China
Japan
Southeast Asia
India
Global Active Pharmaceutical Ingredient market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including
Teva
Novartis
Pfizer
Johnson & Johnson
Mylan
North China Pharmaceutical Group
Dr. Reddy’s Laboratories
Roche
Aurobindo pharma
Sun Pharmaceutical Industries
Boehringer Ingelheim GmbH
Bayer
BASF
DSM
Zhejiang Medicine
Biocon
Johnson Matthey
Hisun Pharmacy
Cambrex
Shandong Xinhua Pharmaceutical
Lonza group
Huahai Pharmaceutical
Haerbin Pharmaceutical Group
Cipla
Tian Yao
Lupin
North East Pharmaceutical
Albemarle
Shandong Lukang Pharmaceutical
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
Synthetic API
Biotech API
Other
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate of Active Pharmaceutical Ingredient for each application, including
Chemical
Deodorant
Dailylife

If you have any special requirements, please let us know and we will offer you the report as you want.

【レポートの目次】

Table of Contents

Global Active Pharmaceutical Ingredient Market Research Report 2017
1 Active Pharmaceutical Ingredient Market Overview
1.1 Product Overview and Scope of Active Pharmaceutical Ingredient
1.2 Active Pharmaceutical Ingredient Segment by Type (Product Category)
1.2.1 Global Active Pharmaceutical Ingredient Production and CAGR (%) Comparison by Type (Product Category) (2012-2022)
1.2.2 Global Active Pharmaceutical Ingredient Production Market Share by Type (Product Category) in 2016
1.2.3 Synthetic API
1.2.4 Biotech API
1.2.5 Other
1.3 Global Active Pharmaceutical Ingredient Segment by Application
1.3.1 Active Pharmaceutical Ingredient Consumption (Sales) Comparison by Application (2012-2022)
1.3.2 Chemical
1.3.3 Deodorant
1.3.4 Dailylife
1.4 Global Active Pharmaceutical Ingredient Market by Region (2012-2022)
1.4.1 Global Active Pharmaceutical Ingredient Market Size (Value) and CAGR (%) Comparison by Region (2012-2022)
1.4.2 North America Status and Prospect (2012-2022)
1.4.3 Europe Status and Prospect (2012-2022)
1.4.4 China Status and Prospect (2012-2022)
1.4.5 Japan Status and Prospect (2012-2022)
1.4.6 Southeast Asia Status and Prospect (2012-2022)
1.4.7 India Status and Prospect (2012-2022)
1.5 Global Market Size (Value) of Active Pharmaceutical Ingredient (2012-2022)
1.5.1 Global Active Pharmaceutical Ingredient Revenue Status and Outlook (2012-2022)
1.5.2 Global Active Pharmaceutical Ingredient Capacity, Production Status and Outlook (2012-2022)

2 Global Active Pharmaceutical Ingredient Market Competition by Manufacturers
2.1 Global Active Pharmaceutical Ingredient Capacity, Production and Share by Manufacturers (2012-2017)
2.1.1 Global Active Pharmaceutical Ingredient Capacity and Share by Manufacturers (2012-2017)
2.1.2 Global Active Pharmaceutical Ingredient Production and Share by Manufacturers (2012-2017)
2.2 Global Active Pharmaceutical Ingredient Revenue and Share by Manufacturers (2012-2017)
2.3 Global Active Pharmaceutical Ingredient Average Price by Manufacturers (2012-2017)
2.4 Manufacturers Active Pharmaceutical Ingredient Manufacturing Base Distribution, Sales Area and Product Type
2.5 Active Pharmaceutical Ingredient Market Competitive Situation and Trends
2.5.1 Active Pharmaceutical Ingredient Market Concentration Rate
2.5.2 Active Pharmaceutical Ingredient Market Share of Top 3 and Top 5 Manufacturers
2.5.3 Mergers & Acquisitions, Expansion

3 Global Active Pharmaceutical Ingredient Capacity, Production, Revenue (Value) by Region (2012-2017)
3.1 Global Active Pharmaceutical Ingredient Capacity and Market Share by Region (2012-2017)
3.2 Global Active Pharmaceutical Ingredient Production and Market Share by Region (2012-2017)
3.3 Global Active Pharmaceutical Ingredient Revenue (Value) and Market Share by Region (2012-2017)
3.4 Global Active Pharmaceutical Ingredient Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.5 North America Active Pharmaceutical Ingredient Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.6 Europe Active Pharmaceutical Ingredient Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.7 China Active Pharmaceutical Ingredient Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.8 Japan Active Pharmaceutical Ingredient Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.9 Southeast Asia Active Pharmaceutical Ingredient Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.10 India Active Pharmaceutical Ingredient Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

4 Global Active Pharmaceutical Ingredient Supply (Production), Consumption, Export, Import by Region (2012-2017)
4.1 Global Active Pharmaceutical Ingredient Consumption by Region (2012-2017)
4.2 North America Active Pharmaceutical Ingredient Production, Consumption, Export, Import (2012-2017)
4.3 Europe Active Pharmaceutical Ingredient Production, Consumption, Export, Import (2012-2017)
4.4 China Active Pharmaceutical Ingredient Production, Consumption, Export, Import (2012-2017)
4.5 Japan Active Pharmaceutical Ingredient Production, Consumption, Export, Import (2012-2017)
4.6 Southeast Asia Active Pharmaceutical Ingredient Production, Consumption, Export, Import (2012-2017)
4.7 India Active Pharmaceutical Ingredient Production, Consumption, Export, Import (2012-2017)

5 Global Active Pharmaceutical Ingredient Production, Revenue (Value), Price Trend by Type
5.1 Global Active Pharmaceutical Ingredient Production and Market Share by Type (2012-2017)
5.2 Global Active Pharmaceutical Ingredient Revenue and Market Share by Type (2012-2017)
5.3 Global Active Pharmaceutical Ingredient Price by Type (2012-2017)
5.4 Global Active Pharmaceutical Ingredient Production Growth by Type (2012-2017)

6 Global Active Pharmaceutical Ingredient Market Analysis by Application
6.1 Global Active Pharmaceutical Ingredient Consumption and Market Share by Application (2012-2017)
6.2 Global Active Pharmaceutical Ingredient Consumption Growth Rate by Application (2012-2017)
6.3 Market Drivers and Opportunities
6.3.1 Potential Applications
6.3.2 Emerging Markets/Countries

7 Global Active Pharmaceutical Ingredient Manufacturers Profiles/Analysis
7.1 Teva
7.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.1.2 Active Pharmaceutical Ingredient Product Category, Application and Specification
7.1.2.1 Product A
7.1.2.2 Product B
7.1.3 Teva Active Pharmaceutical Ingredient Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.1.4 Main Business/Business Overview
7.2 Novartis
7.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.2.2 Active Pharmaceutical Ingredient Product Category, Application and Specification
7.2.2.1 Product A
7.2.2.2 Product B
7.2.3 Novartis Active Pharmaceutical Ingredient Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.2.4 Main Business/Business Overview
7.3 Pfizer
7.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.3.2 Active Pharmaceutical Ingredient Product Category, Application and Specification
7.3.2.1 Product A
7.3.2.2 Product B
7.3.3 Pfizer Active Pharmaceutical Ingredient Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.3.4 Main Business/Business Overview
7.4 Johnson & Johnson
7.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.4.2 Active Pharmaceutical Ingredient Product Category, Application and Specification
7.4.2.1 Product A
7.4.2.2 Product B
7.4.3 Johnson & Johnson Active Pharmaceutical Ingredient Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.4.4 Main Business/Business Overview
7.5 Mylan
7.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.5.2 Active Pharmaceutical Ingredient Product Category, Application and Specification
7.5.2.1 Product A
7.5.2.2 Product B
7.5.3 Mylan Active Pharmaceutical Ingredient Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.5.4 Main Business/Business Overview
7.6 North China Pharmaceutical Group
7.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.6.2 Active Pharmaceutical Ingredient Product Category, Application and Specification
7.6.2.1 Product A
7.6.2.2 Product B
7.6.3 North China Pharmaceutical Group Active Pharmaceutical Ingredient Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.6.4 Main Business/Business Overview
7.7 Dr. Reddy’s Laboratories
7.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.7.2 Active Pharmaceutical Ingredient Product Category, Application and Specification
7.7.2.1 Product A
7.7.2.2 Product B
7.7.3 Dr. Reddy’s Laboratories Active Pharmaceutical Ingredient Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.7.4 Main Business/Business Overview
7.8 Roche
7.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.8.2 Active Pharmaceutical Ingredient Product Category, Application and Specification
7.8.2.1 Product A
7.8.2.2 Product B
7.8.3 Roche Active Pharmaceutical Ingredient Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.8.4 Main Business/Business Overview
7.9 Aurobindo pharma
7.9.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.9.2 Active Pharmaceutical Ingredient Product Category, Application and Specification
7.9.2.1 Product A
7.9.2.2 Product B
7.9.3 Aurobindo pharma Active Pharmaceutical Ingredient Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.9.4 Main Business/Business Overview
7.10 Sun Pharmaceutical Industries
7.10.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.10.2 Active Pharmaceutical Ingredient Product Category, Application and Specification
7.10.2.1 Product A
7.10.2.2 Product B
7.10.3 Sun Pharmaceutical Industries Active Pharmaceutical Ingredient Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.10.4 Main Business/Business Overview
7.11 Boehringer Ingelheim GmbH
7.12 Bayer
7.13 BASF
7.14 DSM
7.15 Zhejiang Medicine
7.16 Biocon
7.17 Johnson Matthey
7.18 Hisun Pharmacy
7.19 Cambrex
7.20 Shandong Xinhua Pharmaceutical
7.21 Lonza group
7.22 Huahai Pharmaceutical
7.23 Haerbin Pharmaceutical Group
7.24 Cipla
7.25 Tian Yao
7.26 Lupin
7.27 North East Pharmaceutical
7.28 Albemarle
7.29 Shandong Lukang Pharmaceutical

8 Active Pharmaceutical Ingredient Manufacturing Cost Analysis
8.1 Active Pharmaceutical Ingredient Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Price Trend of Key Raw Materials
8.1.3 Key Suppliers of Raw Materials
8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.2.1 Raw Materials
8.2.2 Labor Cost
8.2.3 Manufacturing Expenses
8.3 Manufacturing Process Analysis of Active Pharmaceutical Ingredient

9 Industrial Chain, Sourcing Strategy and Downstream Buyers
9.1 Active Pharmaceutical Ingredient Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of Active Pharmaceutical Ingredient Major Manufacturers in 2015
9.4 Downstream Buyers

10 Marketing Strategy Analysis, Distributors/Traders
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List

11 Market Effect Factors Analysis
11.1 Technology Progress/Risk
11.1.1 Substitutes Threat
11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change

12 Global Active Pharmaceutical Ingredient Market Forecast (2017-2022)
12.1 Global Active Pharmaceutical Ingredient Capacity, Production, Revenue Forecast (2017-2022)
12.1.1 Global Active Pharmaceutical Ingredient Capacity, Production and Growth Rate Forecast (2017-2022)
12.1.2 Global Active Pharmaceutical Ingredient Revenue and Growth Rate Forecast (2017-2022)
12.1.3 Global Active Pharmaceutical Ingredient Price and Trend Forecast (2017-2022)
12.2 Global Active Pharmaceutical Ingredient Production, Consumption , Import and Export Forecast by Region (2017-2022)
12.2.1 North America Active Pharmaceutical Ingredient Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
12.2.2 Europe Active Pharmaceutical Ingredient Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
12.2.3 China Active Pharmaceutical Ingredient Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
12.2.4 Japan Active Pharmaceutical Ingredient Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
12.2.5 Southeast Asia Active Pharmaceutical Ingredient Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
12.2.6 India Active Pharmaceutical Ingredient Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
12.3 Global Active Pharmaceutical Ingredient Production, Revenue and Price Forecast by Type (2017-2022)
12.4 Global Active Pharmaceutical Ingredient Consumption Forecast by Application (2017-2022)

13 Research Findings and Conclusion

14 Appendix
14.1 Methodology/Research Approach
14.1.1 Research Programs/Design
14.1.2 Market Size Estimation
14.1.3 Market Breakdown and Data Triangulation
14.2 Data Source
14.2.1 Secondary Sources
14.2.2 Primary Sources
14.3 Disclaimer

List of Tables and Figures

Figure Picture of Active Pharmaceutical Ingredient
Figure Global Active Pharmaceutical Ingredient Production (K MT) and CAGR (%) Comparison by Types (Product Category) (2012-2022)
Figure Global Active Pharmaceutical Ingredient Production Market Share by Types (Product Category) in 2016
Figure Product Picture of Synthetic API
Table Major Manufacturers of Synthetic API
Figure Product Picture of Biotech API
Table Major Manufacturers of Biotech API
Figure Product Picture of Other
Table Major Manufacturers of Other
Figure Global Active Pharmaceutical Ingredient Consumption (K MT) by Applications (2012-2022)
Figure Global Active Pharmaceutical Ingredient Consumption Market Share by Applications in 2016
Figure Chemical Examples
Table Key Downstream Customer in Chemical
Figure Deodorant Examples
Table Key Downstream Customer in Deodorant
Figure Dailylife Examples
Table Key Downstream Customer in Dailylife
Figure Global Active Pharmaceutical Ingredient Market Size (Million USD), Comparison (K MT) and CAGR (%) by Regions (2012-2022)
Figure North America Active Pharmaceutical Ingredient Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe Active Pharmaceutical Ingredient Revenue (Million USD) and Growth Rate (2012-2022)
Figure China Active Pharmaceutical Ingredient Revenue (Million USD) and Growth Rate (2012-2022)
Figure Japan Active Pharmaceutical Ingredient Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southeast Asia Active Pharmaceutical Ingredient Revenue (Million USD) and Growth Rate (2012-2022)
Figure India Active Pharmaceutical Ingredient Revenue (Million USD) and Growth Rate (2012-2022)
Figure Global Active Pharmaceutical Ingredient Revenue (Million USD) Status and Outlook (2012-2022)
Figure Global Active Pharmaceutical Ingredient Capacity, Production (K MT) Status and Outlook (2012-2022)
Figure Global Active Pharmaceutical Ingredient Major Players Product Capacity (K MT) (2012-2017)
Table Global Active Pharmaceutical Ingredient Capacity (K MT) of Key Manufacturers (2012-2017)
Table Global Active Pharmaceutical Ingredient Capacity Market Share of Key Manufacturers (2012-2017)
Figure Global Active Pharmaceutical Ingredient Capacity (K MT) of Key Manufacturers in 2016
Figure Global Active Pharmaceutical Ingredient Capacity (K MT) of Key Manufacturers in 2017
Figure Global Active Pharmaceutical Ingredient Major Players Product Production (K MT) (2012-2017)
Table Global Active Pharmaceutical Ingredient Production (K MT) of Key Manufacturers (2012-2017)
Table Global Active Pharmaceutical Ingredient Production Share by Manufacturers (2012-2017)
Figure 2016 Active Pharmaceutical Ingredient Production Share by Manufacturers
Figure 2017 Active Pharmaceutical Ingredient Production Share by Manufacturers
Figure Global Active Pharmaceutical Ingredient Major Players Product Revenue (Million USD) (2012-2017)
Table Global Active Pharmaceutical Ingredient Revenue (Million USD) by Manufacturers (2012-2017)
Table Global Active Pharmaceutical Ingredient Revenue Share by Manufacturers (2012-2017)
Table 2016 Global Active Pharmaceutical Ingredient Revenue Share by Manufacturers
Table 2017 Global Active Pharmaceutical Ingredient Revenue Share by Manufacturers
Table Global Market Active Pharmaceutical Ingredient Average Price (USD/MT) of Key Manufacturers (2012-2017)
Figure Global Market Active Pharmaceutical Ingredient Average Price (USD/MT) of Key Manufacturers in 2016
Table Manufacturers Active Pharmaceutical Ingredient Manufacturing Base Distribution and Sales Area
Table Manufacturers Active Pharmaceutical Ingredient Product Category
Figure Active Pharmaceutical Ingredient Market Share of Top 3 Manufacturers
Figure Active Pharmaceutical Ingredient Market Share of Top 5 Manufacturers
Table Global Active Pharmaceutical Ingredient Capacity (K MT) by Region (2012-2017)
Figure Global Active Pharmaceutical Ingredient Capacity Market Share by Region (2012-2017)
Figure Global Active Pharmaceutical Ingredient Capacity Market Share by Region (2012-2017)
Figure 2016 Global Active Pharmaceutical Ingredient Capacity Market Share by Region
Table Global Active Pharmaceutical Ingredient Production by Region (2012-2017)
Figure Global Active Pharmaceutical Ingredient Production (K MT) by Region (2012-2017)
Figure Global Active Pharmaceutical Ingredient Production Market Share by Region (2012-2017)
Figure 2016 Global Active Pharmaceutical Ingredient Production Market Share by Region
Table Global Active Pharmaceutical Ingredient Revenue (Million USD) by Region (2012-2017)
Table Global Active Pharmaceutical Ingredient Revenue Market Share by Region (2012-2017)
Figure Global Active Pharmaceutical Ingredient Revenue Market Share by Region (2012-2017)
Table 2016 Global Active Pharmaceutical Ingredient Revenue Market Share by Region
Figure Global Active Pharmaceutical Ingredient Capacity, Production (K MT) and Growth Rate (2012-2017)
Table Global Active Pharmaceutical Ingredient Capacity, Production (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Table North America Active Pharmaceutical Ingredient Capacity, Production (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Table Europe Active Pharmaceutical Ingredient Capacity, Production (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Table China Active Pharmaceutical Ingredient Capacity, Production (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Table Japan Active Pharmaceutical Ingredient Capacity, Production (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Table Southeast Asia Active Pharmaceutical Ingredient Capacity, Production (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Table India Active Pharmaceutical Ingredient Capacity, Production (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Table Global Active Pharmaceutical Ingredient Consumption (K MT) Market by Region (2012-2017)
Table Global Active Pharmaceutical Ingredient Consumption Market Share by Region (2012-2017)
Figure Global Active Pharmaceutical Ingredient Consumption Market Share by Region (2012-2017)
Figure 2016 Global Active Pharmaceutical Ingredient Consumption (K MT) Market Share by Region
Table North America Active Pharmaceutical Ingredient Production, Consumption, Import & Export (K MT) (2012-2017)
Table Europe Active Pharmaceutical Ingredient Production, Consumption, Import & Export (K MT) (2012-2017)
Table China Active Pharmaceutical Ingredient Production, Consumption, Import & Export (K MT) (2012-2017)
Table Japan Active Pharmaceutical Ingredient Production, Consumption, Import & Export (K MT) (2012-2017)
Table Southeast Asia Active Pharmaceutical Ingredient Production, Consumption, Import & Export (K MT) (2012-2017)
Table India Active Pharmaceutical Ingredient Production, Consumption, Import & Export (K MT) (2012-2017)
Table Global Active Pharmaceutical Ingredient Production (K MT) by Type (2012-2017)
Table Global Active Pharmaceutical Ingredient Production Share by Type (2012-2017)
Figure Production Market Share of Active Pharmaceutical Ingredient by Type (2012-2017)
Figure 2016 Production Market Share of Active Pharmaceutical Ingredient by Type
Table Global Active Pharmaceutical Ingredient Revenue (Million USD) by Type (2012-2017)
Table Global Active Pharmaceutical Ingredient Revenue Share by Type (2012-2017)
Figure Production Revenue Share of Active Pharmaceutical Ingredient by Type (2012-2017)
Figure 2016 Revenue Market Share of Active Pharmaceutical Ingredient by Type
Table Global Active Pharmaceutical Ingredient Price (USD/MT) by Type (2012-2017)
Figure Global Active Pharmaceutical Ingredient Production Growth by Type (2012-2017)
Table Global Active Pharmaceutical Ingredient Consumption (K MT) by Application (2012-2017)
Table Global Active Pharmaceutical Ingredient Consumption Market Share by Application (2012-2017)
Figure Global Active Pharmaceutical Ingredient Consumption Market Share by Applications (2012-2017)
Figure Global Active Pharmaceutical Ingredient Consumption Market Share by Application in 2016
Table Global Active Pharmaceutical Ingredient Consumption Growth Rate by Application (2012-2017)
Figure Global Active Pharmaceutical Ingredient Consumption Growth Rate by Application (2012-2017)
Table Teva Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Teva Active Pharmaceutical Ingredient Capacity, Production (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Teva Active Pharmaceutical Ingredient Production Growth Rate (2012-2017)
Figure Teva Active Pharmaceutical Ingredient Production Market Share (2012-2017)
Figure Teva Active Pharmaceutical Ingredient Revenue Market Share (2012-2017)
Table Novartis Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Novartis Active Pharmaceutical Ingredient Capacity, Production (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Novartis Active Pharmaceutical Ingredient Production Growth Rate (2012-2017)
Figure Novartis Active Pharmaceutical Ingredient Production Market Share (2012-2017)
Figure Novartis Active Pharmaceutical Ingredient Revenue Market Share (2012-2017)
Table Pfizer Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Pfizer Active Pharmaceutical Ingredient Capacity, Production (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Pfizer Active Pharmaceutical Ingredient Production Growth Rate (2012-2017)
Figure Pfizer Active Pharmaceutical Ingredient Production Market Share (2012-2017)
Figure Pfizer Active Pharmaceutical Ingredient Revenue Market Share (2012-2017)
Table Johnson & Johnson Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Johnson & Johnson Active Pharmaceutical Ingredient Capacity, Production (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Johnson & Johnson Active Pharmaceutical Ingredient Production Growth Rate (2012-2017)
Figure Johnson & Johnson Active Pharmaceutical Ingredient Production Market Share (2012-2017)
Figure Johnson & Johnson Active Pharmaceutical Ingredient Revenue Market Share (2012-2017)
Table Mylan Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Mylan Active Pharmaceutical Ingredient Capacity, Production (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Mylan Active Pharmaceutical Ingredient Production Growth Rate (2012-2017)
Figure Mylan Active Pharmaceutical Ingredient Production Market Share (2012-2017)
Figure Mylan Active Pharmaceutical Ingredient Revenue Market Share (2012-2017)
Table North China Pharmaceutical Group Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table North China Pharmaceutical Group Active Pharmaceutical Ingredient Capacity, Production (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure North China Pharmaceutical Group Active Pharmaceutical Ingredient Production Growth Rate (2012-2017)
Figure North China Pharmaceutical Group Active Pharmaceutical Ingredient Production Market Share (2012-2017)
Figure North China Pharmaceutical Group Active Pharmaceutical Ingredient Revenue Market Share (2012-2017)
Table Dr. Reddy’s Laboratories Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Dr. Reddy’s Laboratories Active Pharmaceutical Ingredient Capacity, Production (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Dr. Reddy’s Laboratories Active Pharmaceutical Ingredient Production Growth Rate (2012-2017)
Figure Dr. Reddy’s Laboratories Active Pharmaceutical Ingredient Production Market Share (2012-2017)
Figure Dr. Reddy’s Laboratories Active Pharmaceutical Ingredient Revenue Market Share (2012-2017)
Table Roche Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Roche Active Pharmaceutical Ingredient Capacity, Production (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Roche Active Pharmaceutical Ingredient Production Growth Rate (2012-2017)
Figure Roche Active Pharmaceutical Ingredient Production Market Share (2012-2017)
Figure Roche Active Pharmaceutical Ingredient Revenue Market Share (2012-2017)
Table Aurobindo pharma Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Aurobindo pharma Active Pharmaceutical Ingredient Capacity, Production (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Aurobindo pharma Active Pharmaceutical Ingredient Production Growth Rate (2012-2017)
Figure Aurobindo pharma Active Pharmaceutical Ingredient Production Market Share (2012-2017)
Figure Aurobindo pharma Active Pharmaceutical Ingredient Revenue Market Share (2012-2017)
Table Sun Pharmaceutical Industries Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Sun Pharmaceutical Industries Active Pharmaceutical Ingredient Capacity, Production (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Sun Pharmaceutical Industries Active Pharmaceutical Ingredient Production Growth Rate (2012-2017)
Figure Sun Pharmaceutical Industries Active Pharmaceutical Ingredient Production Market Share (2012-2017)
Figure Sun Pharmaceutical Industries Active Pharmaceutical Ingredient Revenue Market Share (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Active Pharmaceutical Ingredient
Figure Manufacturing Process Analysis of Active Pharmaceutical Ingredient
Figure Active Pharmaceutical Ingredient Industrial Chain Analysis
Table Raw Materials Sources of Active Pharmaceutical Ingredient Major Manufacturers in 2016
Table Major Buyers of Active Pharmaceutical Ingredient
Table Distributors/Traders List
Figure Global Active Pharmaceutical Ingredient Capacity, Production (K MT) and Growth Rate Forecast (2017-2022)
Figure Global Active Pharmaceutical Ingredient Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Global Active Pharmaceutical Ingredient Price (Million USD) and Trend Forecast (2017-2022)
Table Global Active Pharmaceutical Ingredient Production (K MT) Forecast by Region (2017-2022)
Figure Global Active Pharmaceutical Ingredient Production Market Share Forecast by Region (2017-2022)
Table Global Active Pharmaceutical Ingredient Consumption (K MT) Forecast by Region (2017-2022)
Figure Global Active Pharmaceutical Ingredient Consumption Market Share Forecast by Region (2017-2022)
Figure North America Active Pharmaceutical Ingredient Production (K MT) and Growth Rate Forecast (2017-2022)
Figure North America Active Pharmaceutical Ingredient Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table North America Active Pharmaceutical Ingredient Production, Consumption, Export and Import (K MT) Forecast (2017-2022)
Figure Europe Active Pharmaceutical Ingredient Production (K MT) and Growth Rate Forecast (2017-2022)
Figure Europe Active Pharmaceutical Ingredient Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table Europe Active Pharmaceutical Ingredient Production, Consumption, Export and Import (K MT) Forecast (2017-2022)
Figure China Active Pharmaceutical Ingredient Production (K MT) and Growth Rate Forecast (2017-2022)
Figure China Active Pharmaceutical Ingredient Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table China Active Pharmaceutical Ingredient Production, Consumption, Export and Import (K MT) Forecast (2017-2022)
Figure Japan Active Pharmaceutical Ingredient Production (K MT) and Growth Rate Forecast (2017-2022)
Figure Japan Active Pharmaceutical Ingredient Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table Japan Active Pharmaceutical Ingredient Production, Consumption, Export and Import (K MT) Forecast (2017-2022)
Figure Southeast Asia Active Pharmaceutical Ingredient Production (K MT) and Growth Rate Forecast (2017-2022)
Figure Southeast Asia Active Pharmaceutical Ingredient Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table Southeast Asia Active Pharmaceutical Ingredient Production, Consumption, Export and Import (K MT) Forecast (2017-2022)
Figure India Active Pharmaceutical Ingredient Production (K MT) and Growth Rate Forecast (2017-2022)
Figure India Active Pharmaceutical Ingredient Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table India Active Pharmaceutical Ingredient Production, Consumption, Export and Import (K MT) Forecast (2017-2022)
Table Global Active Pharmaceutical Ingredient Production (K MT) Forecast by Type (2017-2022)
Figure Global Active Pharmaceutical Ingredient Production (K MT) Forecast by Type (2017-2022)
Table Global Active Pharmaceutical Ingredient Revenue (Million USD) Forecast by Type (2017-2022)
Figure Global Active Pharmaceutical Ingredient Revenue Market Share Forecast by Type (2017-2022)
Table Global Active Pharmaceutical Ingredient Price Forecast by Type (2017-2022)
Table Global Active Pharmaceutical Ingredient Consumption (K MT) Forecast by Application (2017-2022)
Figure Global Active Pharmaceutical Ingredient Consumption (K MT) Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Source



【免責事項】
※当レポート上の情報/データは調査会社が信頼できると判断した情報源から入手したものに基づき作成しましたが、その正確性・完全性を保証するものではありません。当レポートに記載された情報/データ/見解/仮説などは作成時点又は発行時点における調査会社の判断であり、その後の状況変化に応じて変更される場合があります。当レポート上の情報/データに基づいたお客様の意思決定又は実行による結果について、調査会社/発行会社/販売会社H&Iグローバルリサーチはその責を負いかねますのでご了承ください。英文資料の紹介ページにおける日本語題名/概要/目次はH&Iグローバルリサーチが翻訳した内容であり、翻訳の正確性・完全性を保証するものではありません。

[医薬品有効成分の世界市場] (Global Active Pharmaceutical Ingredient Market Research Report 2017 / QYR7055235)についてメールでお問い合わせはこちら


◆H&Iグローバルリサーチ株式会社のお客様(例)◆